Synonyms: compound (R)-1 [PMID: 40036600] | DFV-890 | IFM-2427 | IFM2427
Compound class:
Synthetic organic
Comment: The discovery of (R)-DFV890 is reported in [3]. It is an NLRP3 inflammasome inhibitor that is intended for anti-inflammatory action.
|
|
References |
1. Gatlik E, Mehes B, Voltz E, Sommer U, Tritto E, Lestini G, Liu X, Pal P, Velinova M, Denney WS et al.. (2024)
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor. Clin Transl Sci, 17 (5): e13789. [PMID:38761014] |
2. Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K et al.. (2023)
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection, 51 (3): 641-654. [PMID:36104613] |
3. Shen DM, Byth KF, Bertheloot D, Braams S, Bradley S, Dean D, Dekker C, El-Kattan AF, Franchi L, Glick GD et al.. (2025)
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor. J Med Chem, 68 (5): 5529-5550. [PMID:40036600] |